16-56758527-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014669.5(NUP93):c.180-11T>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,596,650 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0017 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 21 hom. )
Consequence
NUP93
NM_014669.5 splice_polypyrimidine_tract, intron
NM_014669.5 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.9148
2
Clinical Significance
Conservation
PhyloP100: -0.132
Genes affected
NUP93 (HGNC:28958): (nucleoporin 93) The nuclear pore complex is a massive structure that extends across the nuclear envelope, forming a gateway that regulates the flow of macromolecules between the nucleus and the cytoplasm. Nucleoporins are the main components of the nuclear pore complex in eukaryotic cells. This gene encodes a nucleoporin protein that localizes both to the basket of the pore and to the nuclear entry of the central gated channel of the pore. The encoded protein is a target of caspase cysteine proteases that play a central role in programmed cell death by apoptosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-56758527-T-A is Benign according to our data. Variant chr16-56758527-T-A is described in ClinVar as [Benign]. Clinvar id is 1640265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00167 (255/152266) while in subpopulation EAS AF= 0.0424 (220/5184). AF 95% confidence interval is 0.0378. There are 7 homozygotes in gnomad4. There are 149 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUP93 | NM_014669.5 | c.180-11T>A | splice_polypyrimidine_tract_variant, intron_variant | ENST00000308159.10 | NP_055484.3 | |||
NUP93 | XM_005256263.4 | c.180-11T>A | splice_polypyrimidine_tract_variant, intron_variant | XP_005256320.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUP93 | ENST00000308159.10 | c.180-11T>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_014669.5 | ENSP00000310668 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00168 AC: 255AN: 152148Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
255
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00345 AC: 866AN: 251278Hom.: 20 AF XY: 0.00326 AC XY: 443AN XY: 135828
GnomAD3 exomes
AF:
AC:
866
AN:
251278
Hom.:
AF XY:
AC XY:
443
AN XY:
135828
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00101 AC: 1456AN: 1444384Hom.: 21 Cov.: 27 AF XY: 0.000967 AC XY: 696AN XY: 719770
GnomAD4 exome
AF:
AC:
1456
AN:
1444384
Hom.:
Cov.:
27
AF XY:
AC XY:
696
AN XY:
719770
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00167 AC: 255AN: 152266Hom.: 7 Cov.: 32 AF XY: 0.00200 AC XY: 149AN XY: 74434
GnomAD4 genome
AF:
AC:
255
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
149
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
55
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nephrotic syndrome, type 12 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 10, 2022 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at